TrialArthritis research & therapy2016

Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study.

Won Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.